NCT02941224View on ClinicalTrials.gov

First-in-human Evaluation of the SELUTION DCB, a Novel Sirolimus Coated Balloon in Peripheral Arteries

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

September 30, 2019

Conditions

Patients With Peripheral Artery Disease in the SFA or PA

Interventions

DEVICE

SELUTION DCB (sirolimus coated balloon)

Trial Locations (4)

10787

Radiologische Gemeinschaftspraxis Ihre-Radiologen Franziskus - Krankenhaus Berlin, Berlin

12351

Vivantes Klinikum Neukölln, Berlin

14129

Evangelisches Krankenhaus Hubertus, Berlin

79189

Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen

All Listed Sponsors

lead

M.A. Med Alliance S.A.

INDUSTRY

NCT02941224 - First-in-human Evaluation of the SELUTION DCB, a Novel Sirolimus Coated Balloon in Peripheral Arteries | Biotech Hunter | Biotech Hunter